To Assess the Safety, Tolerability and Pharmacokinetics of ACH-000029 in Healthy Subjects
A Phase 1, Single-center, Placebo-controlled, Double-blind, Randomized Trial to Assess the Safety, Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of ACH-000029 in Healthy Subjects